Hiken J, Earls J, Flanagan KC, Wellinghoff RL, et al. Analytical performance of OncoPrism-HNSCC, an RNA-based assay to inform immune checkpoint inhibitor treatment decisions for recurrent/metastatic head and neck squamous cell carcinoma. BMC Cancer 2025;25:21.
PMID: 39773366